Jaguar Animal Health (JAGX)
(Delayed Data from NSDQ)
$0.21 USD
+0.03 (15.56%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $0.20 -0.01 (-3.85%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Brokerage Reports
0 items in cart
Jaguar Animal Health, Inc. [JAGX]
Reports for Purchase
Showing records 21 - 29 ( 29 total )
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Jaguar enters binding agreement to merge with Napo Pharmaceuticals
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Jaguar inks Canalevia deal with Eli Lillys Elanco animal health subsidiary
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Q3 loss better than expected, awaiting additional year-end developments
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Q2 cash burn better than anticipated, business development discussions continue
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Q1 cash burn better than expected, focus on equine correct, in our view
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Jaguar Q4 cash burn inline with expectations, additional cash needed, lower to BUY
Provider: Feltl & Company
Analyst: HAYNOR B
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Company: Jaguar Animal Health, Inc.
Industry: Medical - Biomedical and Genetics
Jaguar goes after dogs, cats, horses and calves - initiate with STRONG BUY
Provider: Feltl & Company
Analyst: HAYNOR B